» Articles » PMID: 34012922

Radiomics Nomograms Based on Multi-Parametric MRI for Preoperative Differential Diagnosis of Malignant and Benign Sinonasal Tumors: A Two-Centre Study

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 May 20
PMID 34012922
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate the efficacy of multi-parametric MRI-based radiomics nomograms for preoperative distinction between benign and malignant sinonasal tumors.

Methods: Data of 244 patients with sinonasal tumor (training set, n=192; test set, n=52) who had undergone pre-contrast MRI, and 101 patients who underwent post-contrast MRI (training set, n=74; test set, n=27) were retrospectively analyzed. Independent predictors of malignancy were identified and their performance were evaluated. Seven radiomics signatures (RSs) using maximum relevance minimum redundancy (mRMR), and the least absolute shrinkage selection operator (LASSO) algorithm were established. The radiomics nomograms, comprising the clinical model and the RS algorithms were built: one based on pre-contrast MRI (RNWOC); the other based on pre-contrast and post-contrast MRI (RNWC). The performances of the models were evaluated with area under the curve (AUC), calibration, and decision curve analysis (DCA) respectively.

Results: The efficacy of the clinical model (AUC=0.81) of RNWC was higher than that of the model (AUC=0.76) of RNWOC in the test set. There was no significant difference in the AUC of radiomic algorithms in the test set. The RS-T1T2 (AUC=0.74) and RS-T1T2T1C (RSWC, AUC=0.81) achieved a good distinction efficacy in the test set. The RNWC and the RNWOC showed excellent distinction (AUC=0.89 and 0.82 respectively) in the test set. The DCA of the nomograms showed better clinical usefulness than the clinical models and radiomics signatures.

Conclusions: The radiomics nomograms combining the clinical model and RS can be accurately, safely and efficiently used to distinguish between benign and malignant sinonasal tumors.

Citing Articles

Artificial intelligence and MRI in sinonasal tumors discrimination: where do we stand?.

Gravante G, Arosio A, Curti N, Biondi R, Berardi L, Gandolfi A Eur Arch Otorhinolaryngol. 2024; 282(3):1557-1566.

PMID: 39719474 DOI: 10.1007/s00405-024-09169-9.


MRI radiomics may predict early tumor recurrence in patients with sinonasal squamous cell carcinoma.

Park C, Choi S, Kim D, Kim S, Han K, Ahn S Eur Radiol. 2023; 34(5):3151-3159.

PMID: 37926740 DOI: 10.1007/s00330-023-10389-6.


Multi-parametric MRI-based radiomics signature for preoperative prediction of Ki-67 proliferation status in sinonasal malignancies: a two-centre study.

Bi S, Li J, Wang T, Man F, Zhang P, Hou F Eur Radiol. 2022; 32(10):6933-6942.

PMID: 35687135 DOI: 10.1007/s00330-022-08780-w.


A Clinical-Radiomics Nomogram Based on the Apparent Diffusion Coefficient (ADC) for Individualized Prediction of the Risk of Early Relapse in Advanced Sinonasal Squamous Cell Carcinoma: A 2-Year Follow-Up Study.

Lin N, Yu S, Lin M, Shi Y, Chen W, Xia Z Front Oncol. 2022; 12:870935.

PMID: 35651794 PMC: 9149576. DOI: 10.3389/fonc.2022.870935.

References
1.
Bi W, Hosny A, Schabath M, Giger M, Birkbak N, Mehrtash A . Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin. 2019; 69(2):127-157. PMC: 6403009. DOI: 10.3322/caac.21552. View

2.
Wood J, Casiano R . Inverted papillomas and benign nonneoplastic lesions of the nasal cavity. Am J Rhinol Allergy. 2012; 26(2):157-63. PMC: 3906506. DOI: 10.2500/ajra.2012.26.3732. View

3.
Vickers A, Cronin A, Elkin E, Gonen M . Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008; 8:53. PMC: 2611975. DOI: 10.1186/1472-6947-8-53. View

4.
Sen S, Chandra A, Mukhopadhyay S, Ghosh P . Sinonasal Tumors: Computed Tomography and MR Imaging Features. Neuroimaging Clin N Am. 2015; 25(4):595-618. DOI: 10.1016/j.nic.2015.07.006. View

5.
Collins G, Reitsma J, Altman D, Moons K . Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015; 350:g7594. DOI: 10.1136/bmj.g7594. View